Genome-wide gene-based analyses of weight loss interventions identify a potential role for NKX6.3 in metabolism
- PMID: 30710084
- PMCID: PMC6358625
- DOI: 10.1038/s41467-019-08492-8
Genome-wide gene-based analyses of weight loss interventions identify a potential role for NKX6.3 in metabolism
Abstract
Hundreds of genetic variants have been associated with Body Mass Index (BMI) through genome-wide association studies (GWAS) using observational cohorts. However, the genetic contribution to efficient weight loss in response to dietary intervention remains unknown. We perform a GWAS in two large low-caloric diet intervention cohorts of obese participants. Two loci close to NKX6.3/MIR486 and RBSG4 are identified in the Canadian discovery cohort (n = 1166) and replicated in the DiOGenes cohort (n = 789). Modulation of HGTX (NKX6.3 ortholog) levels in Drosophila melanogaster leads to significantly altered triglyceride levels. Additional tissue-specific experiments demonstrate an action through the oenocytes, fly hepatocyte-like cells that regulate lipid metabolism. Our results identify genetic variants associated with the efficacy of weight loss in obese subjects and identify a role for NKX6.3 in lipid metabolism, and thereby possibly weight control.
Conflict of interest statement
A.V., J.C., N.G., H.R., G.L., S.M., C.C., O.W., P.M., P.D. and J.H. are full-time employees at Nestlé Institute of Health Sciences SA. D.L. is a member of Institut Universitaire de France. W.H.S. reports having received research support from several food companies such as Nestle, DSM, Unilever, Nutrition et Sante and Danone as well as Pharmaceutical companies such as GSK, Novartis and Novo Nordisk. He is an unpaid scientific advisor for the International Life Science Institute, ILSI Europe. A.A. reports grants or personal fees from McCain Foods, USA, personal fees from McDonald’s, USA, personal fees from Basic Research, USA, personal fees from Nestlé, Lausanne, personal fees from Dutch Beer Knowledge Institute, NL, personal fees from Gelesis, USA, personal fees from Novo Nordisk, DK, personal fees from S-Biotek, DK, grants from Arla Foods, DK, grants from Danish Dairy Research Council, grants from Nordea Foundation, DK, outside the submitted work; and Royalties received for the book first published in Danish as Verdens Bedste Kur (Politiken, Copenhagen) and subsequently published in Dutch as Het beste dieet ter wereld (Kosmos Uitgevers, Utrecht/Antwerpen), and in English as World’s Best Diet (Penguin, Australia). G.N. is supported by an NHMRC career development fellowship II CDF1111940. The remaining authors declare no competing interests.
Figures
References
-
- Haslam DW, James WPT. Obesity. Lancet. 2005;366:1197–1209. - PubMed
-
- Dixon JB. The effect of obesity on health outcomes. Mol. Cell. Endocrinol. 2010;316:104–108. - PubMed
-
- Lean ME. Pathophysiology of obesity. Proc. Nutr. Soc. 2000;59:331–336. - PubMed
-
- Soare A, Weiss EP, Pozzilli P. Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk. Diabetes Metab. Res. Rev. 2014;30:41–47. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
